ALNY
ALNYLAM PHARMACE
Health Care·Biotechnology·UNITED STATES
$291.37
MCap $38.9B
as of 2026-06-26
Total
D1w
Fund
B1w
Quant
E1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-06-27
MIDOS SI
+0.20
Sentiment 28.7%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$291.37
Adaptive Mean
$289.93
+1.44 vs mean
Adaptive σ
3.57
MIDOS BB
$282.79 – $297.08
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-05-15
Composite Z
+1.01
ROE
84.4%
Z +1.68
Rev Gr
96.4%
Z +0.51
EPS Gr
38.1%
Z +0.07
OPM Gr
656.5%
Z +4.15
FCF Yld
1.7%
Z +0.17
EPS Surp
46.1%
Z +0.35
EPS 3mo Δ
-5.2%
Z +0.12
Fwd P/E
21.17
Z —
PEGY
0.56
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-06-27
Q3M
-11.03
Q6M
-9.68
Q12M
-2.21
MA 30/100
0.941
Bearish (MA30 < MA100)
α (Jensen)
-0.7261
β (12M)
0.53
σ (12M)
0.369
Divergence — Fundamentals vs Momentum
Z Percentile
98%
Q Percentile
27%
Divergence
+71.0
Tier
RELOAD — WATCH
Fundamentals well ahead of momentum. Strong reload candidate when momentum inflects.
Kirkpatrick RS & Persistence
RS
-35.0
RS Pctl
13%
RS Decile
D2
Persistence
1w
at grade D
Options / OI Analysis
No options or Williams data available for this ticker.